Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A New Predictor Marker for Cochlear Implants Infection: Neutrophil/ Lymphocyte Ratio

NCT04120181 is registered in ClinicalTrials.gov with Selcuk University as lead sponsor.

NCT NCT04120181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04120181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A New Predictor Marker for Cochlear Implants Infection: Neutrophil/ Lymphocyte Ratio
Lead sponsor
Selcuk University
Phase
Observational
Overall status
Completed
Start date
May 31, 2014
Completion date
October 31, 2018
Enrollment
13 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cochlear hearing loss, implant infection, infection